Neurocrine’s $2.9B Acquisition of Soleno: A Big Move into Rare Disease Market
In a major development in the global biotech sector, Neurocrine Biosciences has announced the acquisition of Soleno Therapeutics…
Merck & Co. to Acquire Terns Pharmaceuticals for $6.7 Billion in Major Cancer Bet
In a major move that highlights the growing competition in the global pharmaceutical industry, US-based drugmaker Merck &…
Eli Lilly Acquires Ventyx for $1.2B to Boost Oral Therapies
Indianapolis, USA: Pharmaceutical giant Eli Lilly & Co. has announced the acquisition of U.S.-based biotech company Ventyx Biosciences…
J&J Acquires Halda Therapeutics for $3.05 Billion — A Big Push in Cancer Treatment
Johnson & Johnson (J&J) has signed a $3.05 billion all-cash agreement to acquire Halda Therapeutics, a U.S.-based clinical-stage…
